AAV9 U7snRNA Gene Therapy to Treat Boys With DMD Exon 2 Duplications.
Clinical trial NCT04240314 · COMPLETED
Trial details
- NCT number
- NCT04240314
- Sponsor
- Megan Waldrop
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-15
- Primary completion
- 2023-11-13
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.